時間 | 主題 | |||
---|---|---|---|---|
Major Advances of Radioligand Therapy in Prostate Cancer
講者:
Bertrand Tombal
座長:
馮思中
|
Bertrand Tombal |
馮思中 |
||
Factors Predicting Biochemical Response and Survival Benefits Following Radioligand Therapy with 177Lu-PSMA in Metastatic Castrate-resistant Prostate Cancer
講者:
Joe O'Sullivan
座長:
蒲永孝
|
Joe O'Sullivan |
蒲永孝 |
||
Patient Selection Considerations for 177Lu-PSMA-617 Treatment
講者:
Michael Hofman
座長:
王昱豐
|
Michael Hofman |
王昱豐 |